RE-BVS – Piemonte Repository

Sfoglia per AUTORE
DIANA A
Collezione ASL Biella

Items : 3

Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study. in Targeted oncology / Target Oncol. 2024 May;19(3):359-370. doi: 10.1007/s11523-024-01060-1. Epub 2024 May 1.

2024
ASL Biella
AOU Città della Salute di Torino

Casadei-Gardini A; Rimassa L; Antonuzzo L; Vivaldi C; Stefano C; Foti S; Rizzato MD; De Braud F; Aldrighetti L; Ratti F; Zanuso V; De Rosa A; Niger M; Rossari F; Fornaro L; Satolli MA; Brandi G; Garattini SK; Brunetti O; Pirrone C; Leone F; Diana A; Pretta A; Toma I; Landriscina M; Lorenzo A; Gusmaroli E; Bergamo F; Balsano R; et alii...

Prognostic and predictive role of FGFR2 and IDH1 targetable alterations in advanced biliary tract cancer (aBTC): Data from the Italian ANITA dataset in Annals of Oncology

2024
ASL Biella

Genovesi V; Rimini M; Pressiani T; Soldà C; Nichetti F; Salvatore L; Antonuzzo L; Silvestro L; Diana A; Leone F; Foti S; Balsano R; Piva VM; Pircher CC; Camera S; Masi G; Rimassa L; De Grandis MC; Gardini AC; Fornaro L;

Extended molecular profiling (EMP) and access to targeted treatment (TT) in advanced biliary tract cancer (BTC): Results from the Italian cholangiocarcinoma dataset (ANITA) in Annals of Oncology

2024
ASL Biella

Genovesi V; Rimini M; Pressiani T; Rizzato MD; Niger M; Salvatore L; Antonuzzo L; Silvestro L; Diana A; Leone F; Salani F; Foti S; Zanuso V; De Rosa A; Pircher CC; Vivaldi C; Rimassa L; Sperotto S; Casadei Gardini A; Fornaro L;